Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned

• Egile Nagusiak: S. F. La Vincente (Egilea), C. von Mollendorf (Egilea), M. Ulziibayar (Egilea), C. Satzke (Egilea), L. Dashtseren (Egilea), K. K. Fox (Egilea), E. M. Dunne (Egilea), C. D. Nguyen (Egilea), J. de Campo (Egilea), M. de Campo (Egilea), H. Thomson (Egilea), G. Surenkhand (Egilea), S. Demberelsuren (Egilea), S. Bujinlkham (Egilea), L. A. H. Do (Egilea), D. Narangerel (Egilea), T. Cherian (Egilea), T. Mungun (Egilea), E. K. Mulholland (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2019-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Streptococcus pneumoniae causes substantial morbidity and mortality among children. The introduction of pneumococcal conjugate vaccines (PCV) has the potential to dramatically reduce disease burden. As with any vaccine, it is important to evaluate PCV impact, to help guide decisi...